StockData
Thermo Fisher Scientific Inc. logo

Thermo Fisher Scientific Inc. (TMO) operating KPIs

TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3027% above fair value
$697.00−12.18 (-1.72%)

Close on Oct 30, 2026Market cap $257.71BP/E 36.8Yield 0.25%

Thermo Fisher Scientific mảng Clinical Diagnostics (Chẩn đoán lâm sàng & xét nghiệm đặc thù) ($M)

SEC 10-K / 10-Q Note 6 (Revenue by Business)

QuarterlyAnnual
Latest, Q2 2026
290
Period ended Jun 30, 2026
Change on a year earlier
+5.1%
276 in Q2 2025
History
10 quarters
Since Q1 2024
Sources
6
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedMảng Clinical Diagnostics (Chẩn đoán lâm sàng & xét nghiệm đặc thù) ($M)Year on yearSource
Q2 2026Jun 30, 2026290+5.1%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2026Mar 31, 2026271+3.0%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q4 2025Dec 31, 2025293+12.3%SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2025Sep 30, 2025283+6.4%SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2025Jun 30, 2025276+1.1%SEC Form 10-Q (10q_2026Q2, filed 2026-07-31) ↗
Q1 2025Mar 31, 20252630.0%SEC Form 10-Q (10q_2026Q1, filed 2026-05-01) ↗
Q4 2024Dec 31, 2024261–SEC Form 10-K (10k_2025, filed 2026-02-26) ↗
Q3 2024Sep 30, 2024266–SEC Form 10-Q (10q_2025Q3, filed 2025-10-31) ↗
Q2 2024Jun 30, 2024273–SEC Form 10-Q (10q_2025Q2, filed 2025-08-01) ↗
Q1 2024Mar 31, 2024263–SEC Form 10-Q (10q_2025Q1, filed 2025-05-02) ↗

Cite this data

StockData. (2026). Thermo Fisher Scientific Mảng Clinical Diagnostics (Chẩn đoán lâm sàng & xét nghiệm đặc thù) ($M), quarterly Q1 2024–Q2 2026 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/rev_biz_clinical_diagnostics

See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.